The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone
compounds useful as inhibitors of serine proteases of the coagulation cascade and
compounds, compositions and methods for anticoagulant therapy for the treatment
and prevention of a variety of thrombotic conditions including coronary artery
and cerebrovascular diseases.
